Aylin Balci Özyurt

Aylin Balci Özyurt

Auto-generated profile, based on publicly available information

Aylin Balci Özyurt

Department of Pharmaceutical Toxicology Bahçeşehir University School of Pharmacy İstanbul Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
BOBusra Ozyurt
Busra Ozyurt
GOGizem Ozkemahli
Gizem Ozkemahli
AYAnıl Yirün
Anıl Yirün
AOAylin Balci Ozyurt
Aylin Balci Ozyurt
MBMerve Gudul Bacanli
Merve Gudul Bacanli
PEPinar Erkekoglu
Pinar Erkekoglu
Bisphenol A (BPA) BPA is an endocrine-disrupting chemical that has a wide range of uses. Exposure to BPA can be by oral, inhalation, and parenteral routes. Although its use in several products is limited, there is still concern on its adverse health effects, particularly for susceptible populations like children. Alternative bisphenols, such as bisphenol S (BPS) and bisphenol F (BPF), are now being used instead of BPA, although there is little information on the toxicity of these bisphenols. BPF is used as a plasticizer in the production of several industrial materials as well as in the coating of drinks and food cans. BPS is used in curing fast-drying epoxy glues, as a corrosion inhibitor and as a reactant in polymer reactions. In this study, the possible toxic effects of BPA, BPS, and BPF in HepG2 cells were evaluated comparatively. For this purpose, their effects on cytotoxicity, production of intracellular reactive oxygen species (ROS), oxidant/antioxidant parameters, and DNA damage have been examined. The cytotoxicity potentials of different bisphenols were found to be as BPS > BPF > BPA. All bisphenol derivatives caused increases in intracellular ROS production. We observed that all bisphenol derivatives cause an imbalance in some oxidant/antioxidant parameters. Bisphenols also caused significant DNA damage in order of BPF > BPA > BPS. We can suggest that both of the bisphenol derivatives used as alternatives to BPA also showed similar toxicities and may not be considered as safe alternatives. Mechanistic studies are needed to elucidate this issue.

12 August 2020 in International Journal of Environmental Health Research
Verified
Journal Article
Closed access
ABAylin Balcı
Aylin Balcı
GÖGizem Özkemahlı
Gizem Özkemahlı
PEPinar Erkekoglu
Pinar Erkekoglu
DZDilara Zeybek
Dilara Zeybek
NYNilgün Yersal
Nilgün Yersal
BKBelma Kocer-Gumusel
Belma Kocer-Gumusel
Bisphenol A (BPA) and phthalates are abundantly used endocrine disrupting chemicals (EDCs). The aim of this study was to evaluate the effects of single and combined exposures to BPA and/or di(2-ethylhexyl) phthalate (DEHP) in prenatal and lactational period on rat male reproductive system in later stages of life. Pregnant Sprague-Dawley rats were divided randomly to four groups (n = 3/group): Control (corn oil); DEHP (30 mg/kg/day); BPA (50 mg/kg/day); and BPA+ DEHP (30 mg/kg/day DEHP and 50 mg/kg/day BPA). Groups exposed to EDCs through 6–21 gestational days and lactation period by intragastric lavage. Male offspring (n = 6/group) from each mother were fed till adulthood and were then euthanized. Later, reproductive hormones, sperm parameters, and oxidative stress parameters were determined. In conclusion, we can suggest that prenatal and lactational exposure to BPA and DEHP may cause adverse effects in male reproductive system in later stages of life especially after combined exposure.

13 April 2022 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
GOGizem Ozkemahli
Gizem Ozkemahli
AOAylin Balci Ozyurt
Aylin Balci Ozyurt
PEPinar Erkekoglu
Pinar Erkekoglu
NZNaciye Dilara Zeybek
Naciye Dilara Zeybek
NYNilgun Yersal
Nilgun Yersal
BKBelma Kocer-Gumusel
Belma Kocer-Gumusel
Bisphenol A (BPA) and di(2-ethylhexyl) phthalate (DEHP) are endocrine disrupting chemicals (EDCs) which are abundantly used in polyvinyl chloride plastics, polycarbonates and epoxy resins. Prenatal and early postnatal exposures to EDCs are suggested to be more critical. Such exposures can lead to reprotoxic effects, hormonal and metabolic consequences in adulthood. Moreover, combined exposure to different EDCs can lead to more serious adverse effects, some of which cannot be predicted by examining their individual toxicity profiles. This study aimed to evaluate effects of single and combined prenatal and lactational exposures to BPA and/or DEHP on female reproductive hormones and ovarian follicle development. Pregnant Sprague-Dawley rats were divided randomly to four groups (n = 3/group): Control (received vehicle only); DEHP (30 mg/kg/day); BPA (50 mg/kg/day) and BPA + DEHP (30 mg/kg/day DEHP; 50 mg/kg/day BPA) through 6-21 gestational days and lactation by intra-gastric lavage. Female offspring (n = 6/group) were fed until the end of twelfth postnatal week and then euthanized. Reproductive hormones, ovarian follicle numbers and ovarian development were determined. Plasma testosterone and estradiol levels of BPA and BPA + DEHP groups were significantly lower than control. In BPA group, the number of tertiary ovarian follicles decreased significantly compared to control. In the combined exposure group, the number of corpus luteum (29%) as well as the number of primordial follicles (36%) showed marked decreases compared to control group. It can be suggested that early life exposure to BPA and DEHP may cause late life adverse effects in female reproductive system especially after combined exposure.

2 July 2025 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ÖTözlem tezol
özlem tezol
SYSıddika Songül Yalçın
Sıddika Songül Yalçın
TRTuba Reçber
Tuba Reçber
AYAnıl Yirün
Anıl Yirün
AÖAylin Balcı Özyurt
Aylin Balcı Özyurt
Emirhan NemutluEmirhan Nemutlu
Emirhan Nemutlu
Spasticity, pain, fatigue and other secondary consequences of spastic CP may lead to metabolic alterations. The aim of this study was to analyze the plasma metabolomic profiles of children with spastic CP and compare these with typically developing controls. This case–control study (n = 50 for CP and n = 55 for control) was conducted between September 2020 and November 2020 at Mersin University Hospital. Three to ten year old patients with spastic CP and age- and sex-matched typically developing controls were included in the study. Data on anthropometric measurements and clinical profiles were collected. Plasma samples were obtained for non-targeted metabolomics. The GC–MS based metabolomics analysis was performed. Metaboanalyst software was used for multivariate analyses, principal component analysis and pathway analyses. Spastic quadriplegia, spastic diplegia and spastic hemiplegia were found in 26 (52%), 14 (28%) and 10 (20%) patients, respectively, and 31 patients (62%) were non-ambulant. Twenty-two patients (44%) had epilepsy and antiepileptic use. Mean weight-for-age, height-for- age, and body mass index z-scores were significantly lower in the CP group (p < 0.05). Total 224 metabolites were detected in all subjects. Of these metabolites, 14 were detected at higher and 37 at lower levels in the CP group compared to the control group. The most significant changes in the CP group were found in aminoacyl-tRNA biosynthesis, tyrosine metabolism, valine, leucine and isoleucine biosynthesis, alanine, aspartate and glutamate metabolism, arginine and proline metabolism, citrate cycle (TCA cycle), galactose metabolism and glutathione metabolism. Forty-five metabolites were statistically significant between control, CP with epilepsy and CP without epilepsy groups. Thirty-four metabolites were statistically significant between control, ambulant CP and non-ambulant CP groups. Plasma of spastic CP children was associated with alterations in energy metabolism and protein synthesis and amino acid metabolism compared to typically developing children. Gross motor functional level and accompanying epilepsy may also alter the metabolite profiles.

1 July 2024 in Toxicology Research
Verified
Journal Article
Open access
PDF file
GDGöksun Demirel
Göksun Demirel
SSSonia Sanajou
Sonia Sanajou
AYAnıl Yirün
Anıl Yirün
DÇDeniz Arca ÇAKIR
Deniz Arca ÇAKIR
AÖAylin Balcı Özyurt
Aylin Balcı Özyurt
PEPinar Erkekoglu
Pinar Erkekoglu
Improving the quality of life in elderly patients and finding new treatment options for neurological diseases such as Alzheimer’s has become one of the priorities in the scientific world. In recent years, the beneficial effects and therapeutic properties of natural foods on neurological health have become a very remarkable issue. Walnut oil (WO) is a promising nutraceutical, with many phytochemicals and polyunsaturated fatty acids and is thought to be promising in the treatment of many neurological diseases and cognitive deficits, such as Alzheimer’s disease (AD). Polyphenolic compounds found in WO enhance intraneuronal signaling and neurogenesis and improve the sequestration of insoluble toxic protein aggregates. The objective of this study was to investigate the potential protective and therapeutic effects of WO in a model of AD induced by retinoic acid (RA) and brain-derived neurotrophic factor (BDNF). In order to achieve this, the experimental groups were formed as follows: Control group, WO group, Alzheimer’s disease (AD) group, AD + WO applied group (AD + WO). WO supplementation almost significantly reduced oxidative stress in the ad model, providing 2-fold protection against protein oxidation. Additionally, WO showed a significant reduction in tau protein levels (2-fold), increased acetylcholine (ACh) levels (12%), and decreased acetylcholine esterase (AChE) activity (~50%). Since it has been known for centuries that WO does show any adverse effects on human health and has neuroprotective properties, it may be used in the treatment of AD as an additional nutraceutical to drug treatments.

26 December 2022 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
OYOzge Yesildemir
Ozge Yesildemir
YAYasemin Akdevelioglu
Yasemin Akdevelioglu
ACAysu Duyan Camurdan
Aysu Duyan Camurdan
BCBahar Cuhaci Cakir
Bahar Cuhaci Cakir
SKSelinay Basak Erdemli Kose
Selinay Basak Erdemli Kose
PEPinar Erkekoglu
Pinar Erkekoglu
This study aimed to estimate and compare dietary exposure to bisphenol A (BPA) in exclusively breastfed (EBF) and breastfed plus formula-fed (BF + FF) infants. A total of 70 mothers and their 0–6 month-old infants (40 in the EBF group and 30 in BF + FF group) were included in the study. After the questionnaire form was applied to the mothers, maternal breast milk, infant formula, and infant urine were collected from mother-infant dyads. Total BPA levels in breast milk, infant formula, and infant urine samples were analyzed by the high-pressure liquid chromatography (HPLC). While BPA was detected in 92.5% of the breast milk samples in the EBF group (mean ± SD = 0.59 ± 0.29 ng/mL), BPA was detected in all of the breast milk samples in the BF + FF group (mean ± SD= 0.72 ± 0.37 ng/mL) (p < 0.05). Similarly, 100% of the infant formula samples in the BF + FF group had detectable levels of BPA (mean ± SD = 7.54 ± 1.77 ng/g formula). The mean urinary BPA levels in the EBF infants (4.33 ± 1.89 µg/g creatinine) were not statistically different from the BF + FF infants (5.81 ± 0.11 µg/g creatinine) (p > 0.05). The average daily BPA intake in EBF infants (0.18 ± 0.13 µg/kg body weight (bw)/day) was found to be significantly higher than in BF + FF infants (0.12 ± 0.09 µg/kg bw/day) (p < 0.05). The estimated dietary intakes of BPA for infants in both groups were below the temporary tolerable daily intake (t-TDI) (4 µg/kg bw/day). Consequently, BPA intake of EBF and BF + FF infants were within safe daily limits during the first six months of life.